607 related articles for article (PubMed ID: 15551290)
1. Cytokine profile of sickle cell disease in Oman.
Pathare A; Al Kindi S; Alnaqdy AA; Daar S; Knox-Macaulay H; Dennison D
Am J Hematol; 2004 Dec; 77(4):323-8. PubMed ID: 15551290
[TBL] [Abstract][Full Text] [Related]
2. Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition.
Keikhaei B; Mohseni AR; Norouzirad R; Alinejadi M; Ghanbari S; Shiravi F; Solgi G
Eur Cytokine Netw; 2013 Mar; 24(1):45-52. PubMed ID: 23608554
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of reticulated platelets in patients with sickle cell diseases.
Noronha JF; Costa FF; Saad ST; Lorand-Metze IG; Grotto HZ
Thromb Res; 2007; 121(2):259-67. PubMed ID: 17521711
[TBL] [Abstract][Full Text] [Related]
4. Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy.
Lanaro C; Franco-Penteado CF; Albuqueque DM; Saad ST; Conran N; Costa FF
J Leukoc Biol; 2009 Feb; 85(2):235-42. PubMed ID: 19004988
[TBL] [Abstract][Full Text] [Related]
5. Sickle cell vaso-occlusive crisis is associated with abnormalities in the ratio of vasoconstrictor to vasodilator prostanoids.
Setty BN; Chen D; Stuart MJ
Pediatr Res; 1995 Jul; 38(1):95-102. PubMed ID: 7478805
[TBL] [Abstract][Full Text] [Related]
6. Interferon production in sickle cell disease.
Taylor SC; Shacks SJ; Villicana SM; Olivares J; Dinkins GA
Lymphokine Res; 1990; 9(3):415-23. PubMed ID: 1697921
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of inflammation, growth factor, and coagulation activation in patients with sickle cell disease.
Qari MH; Dier U; Mousa SA
Clin Appl Thromb Hemost; 2012; 18(2):195-200. PubMed ID: 21949038
[TBL] [Abstract][Full Text] [Related]
8. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome.
Liem RI; O'Gorman MR; Brown DL
Am J Hematol; 2004 May; 76(1):19-25. PubMed ID: 15114592
[TBL] [Abstract][Full Text] [Related]
9. Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis.
van Tits LJ; van Heerde WL; Landburg PP; Boderie MJ; Muskiet FA; Jacobs N; Duits AJ; Schnog JB
Biochem Biophys Res Commun; 2009 Dec; 390(1):161-4. PubMed ID: 19799864
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of pentraxin-3, an acute phase protein, are increased during sickle cell painful crisis.
Nur E; van Beers EJ; Martina S; Cuccovillo I; Otten HM; Schnog JJ; Meijers JC; Mantovani A; Brandjes DP; Bottazzi B; Biemond BJ;
Blood Cells Mol Dis; 2011 Mar; 46(3):189-94. PubMed ID: 21256776
[TBL] [Abstract][Full Text] [Related]
11. Plasma protein C levels in children with sickle cell disease.
Karayalcin G; Lanzkowsky P
Am J Pediatr Hematol Oncol; 1989; 11(3):320-3. PubMed ID: 2782560
[TBL] [Abstract][Full Text] [Related]
12. Effect of low-dose warfarin on D-dimer levels during sickle cell vaso-occlusive crisis: a brief report.
Ahmed S; Siddiqui AK; Iqbal U; Sison CP; Shahid RK; Sheth M; Patel DV; Russo LA
Eur J Haematol; 2004 Mar; 72(3):213-6. PubMed ID: 14962240
[TBL] [Abstract][Full Text] [Related]
13. Serum IL-6, IL-10, and TNFα levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition.
Sarray S; Saleh LR; Lisa Saldanha F; Al-Habboubi HH; Mahdi N; Almawi WY
Cytokine; 2015 Mar; 72(1):43-7. PubMed ID: 25569375
[TBL] [Abstract][Full Text] [Related]
14. Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients.
Bao B; Prasad AS; Beck FW; Snell D; Suneja A; Sarkar FH; Doshi N; Fitzgerald JT; Swerdlow P
Transl Res; 2008 Aug; 152(2):67-80. PubMed ID: 18674741
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary function studies in Kuwaiti children with sickle cell disease and elevated Hb F.
Hijazi Z; Onadeko BO; Khadadah M; Haider MZ; Adekile AD; Al-Habashi H
Int J Clin Pract; 2005 Feb; 59(2):163-7. PubMed ID: 15854191
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state.
Sins JWR; Schimmel M; Luken BM; Nur E; Zeerleder SS; van Tuijn CFJ; Brandjes DPM; Kopatz WF; Urbanus RT; Meijers JCM; Biemond BJ; Fijnvandraat K
J Thromb Haemost; 2017 Jul; 15(7):1392-1402. PubMed ID: 28457019
[TBL] [Abstract][Full Text] [Related]
17. Sickle cell vaso-occlusive crisis induces the release of circulating serum heat shock protein-70.
Adewoye AH; Klings ES; Farber HW; Palaima E; Bausero MA; McMahon L; Odhiambo A; Surinder S; Yoder M; Steinberg MH; Asea A
Am J Hematol; 2005 Mar; 78(3):240-2. PubMed ID: 15726596
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea.
Conran N; Fattori A; Saad ST; Costa FF
Am J Hematol; 2004 Aug; 76(4):343-7. PubMed ID: 15282666
[TBL] [Abstract][Full Text] [Related]
19. Types of crises in sickle cell disease patients presenting at the haematology day care unit (HDCU), University College Hospital (UCH), Ibadan.
Olabode JO; Shokunbi WA
West Afr J Med; 2006; 25(4):284-8. PubMed ID: 17402517
[TBL] [Abstract][Full Text] [Related]
20. An association study of inflammatory cytokine gene polymorphisms in Fabry disease.
Safyan R; Whybra C; Beck M; Elstein D; Altarescu G
Eur Cytokine Netw; 2006 Dec; 17(4):271-5. PubMed ID: 17353161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
